Wolverine Trading’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $43.5M | Buy |
94,200
+11,300
| +14% | +$5.26M | 0.03% | 364 |
|
|
2025
Q2 | $33.8M | Buy |
82,900
+28,100
| +51% | +$11.7M | 0.03% | 319 |
|
|
2025
Q1 | $27.4M | Sell |
54,800
-2,500
| -4% | -$1.35M | 0.03% | 320 |
|
|
2024
Q4 | $29.7M | Sell |
57,300
-26,000
| -31% | -$14.3M | 0.03% | 355 |
|
|
2024
Q3 | $51.2M | Buy |
83,300
+22,500
| +37% | +$13.3M | 0.05% | 204 |
|
|
2024
Q2 | $33.6M | Buy |
60,800
+33,500
| +123% | +$19.2M | 0.04% | 273 |
|
|
2024
Q1 | $15.9M | Sell |
27,300
-133,900
| -83% | -$75.1M | 0.02% | 477 |
|
|
2023
Q4 | $85.6M | Buy |
161,200
+104,400
| +184% | +$50.5M | 0.09% | 115 |
|
|
2023
Q3 | $28.8M | Sell |
56,800
-6,900
| -11% | -$3.68M | 0.03% | 271 |
|
|
2023
Q2 | $32.8M | Buy |
63,700
+5,600
| +10% | +$3.02M | 0.04% | 239 |
|
|
2023
Q1 | $32.7M | Sell |
58,100
-99,700
| -63% | -$56.2M | 0.05% | 241 |
|
|
2022
Q4 | $86.9M | Buy |
157,800
+91,700
| +139% | +$48.6M | 0.13% | 112 |
|
|
2022
Q3 | $34.1M | Buy |
66,100
+19,000
| +40% | +$10.6M | 0.05% | 190 |
|
|
2022
Q2 | $25.2M | Sell |
47,100
-26,600
| -36% | -$14.6M | 0.04% | 247 |
|
|
2022
Q1 | $43.9M | Sell |
73,700
-52,900
| -42% | -$30.4M | 0.06% | 213 |
|
|
2021
Q4 | $84.2M | Sell |
126,600
-27,600
| -18% | -$17.2M | 0.1% | 124 |
|
|
2021
Q3 | $89.4M | Buy |
154,200
+52,500
| +52% | +$28.8M | 0.1% | 121 |
|
|
2021
Q2 | $51.7M | Buy |
101,700
+38,400
| +61% | +$18.1M | 0.08% | 182 |
|
|
2021
Q1 | $28.6M | Sell |
63,300
-22,900
| -27% | -$10.9M | 0.04% | 288 |
|
|
2020
Q4 | $39.8M | Buy |
86,200
+17,700
| +26% | +$8.3M | 0.06% | 207 |
|
|
2020
Q3 | $29.8M | Buy |
68,500
+900
| +1% | +$372K | 0.07% | 197 |
|
|
2020
Q2 | $23.7M | Sell |
67,600
-6,200
| -8% | -$2.08M | 0.06% | 197 |
|
|
2020
Q1 | $21M | Buy |
73,800
+24,500
| +50% | +$7.73M | 0.06% | 211 |
|
|
2019
Q4 | $16M | Buy |
49,300
+4,600
| +10% | +$1.39M | 0.04% | 462 |
|
|
2019
Q3 | $12.8M | Buy |
44,700
+11,300
| +34% | +$3.24M | 0.04% | 429 |
|
|
2019
Q2 | $9.81M | Sell |
33,400
-10,200
| -23% | -$2.81M | 0.03% | 541 |
|
|
2019
Q1 | $11.9M | Sell |
43,600
-27,600
| -39% | -$6.87M | 0.03% | 432 |
|
|
2018
Q4 | $15.8M | Buy |
71,200
+8,100
| +13% | +$1.9M | 0.04% | 319 |
|
|
2018
Q3 | $15.4M | Sell |
63,100
-5,900
| -9% | -$1.36M | 0.03% | 382 |
|
|
2018
Q2 | $14.2M | Hold |
69,000
| – | – | 0.03% | 355 |
|
|
2018
Q1 | $14.2M | Sell |
69,000
-19,400
| -22% | -$4.07M | 0.03% | 355 |
|
|
2017
Q4 | $16.8M | Buy |
88,400
+6,800
| +8% | +$1.3M | 0.06% | 286 |
|
|
2017
Q3 | $15.4M | Buy |
+81,600
| New | +$14.8M | 0.06% | 278 |
|
|
2017
Q1 | – | Sell |
-99,100
| Closed | -$14M | – | 4984 |
|
|
2016
Q4 | $14M | Buy |
99,100
+16,300
| +20% | +$2.4M | 0.07% | 290 |
|
|
2016
Q3 | $12.9M | Buy |
+82,800
| New | +$12.8M | 0.06% | 362 |
|
Other funds holding TMO
Wolverine Trading's TMO Position: Q3 2025 in Review
Wolverine Trading sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 8,682 shares — an estimated $4.04M sold.
Wolverine Trading first reported a position in TMO in Q3 2017 and held it in 30 quarters. The position peaked at $68.6M in Q4 2023. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.
- Wolverine Trading reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
- Wolverine Trading sold 8,682 Thermo Fisher Scientific shares in Q3 2025, an estimated $4.04M.
- Wolverine Trading first reported a position in Thermo Fisher Scientific in Q3 2017 and held it in 30 quarters.
- Wolverine Trading's Thermo Fisher Scientific position peaked at $68.6M in Q4 2023.
- 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.